PT2952191T - Apomorfina sublingual - Google Patents

Apomorfina sublingual

Info

Publication number: PT2952191T
Authority: PT; Portugal
Prior art keywords: sublingual apomorphine; apomorphine; sublingual
Prior art date: 2009-06-12

Application number

PT15175258T

Other languages

English (en)

Inventor

John Giovinazzo Anthony

Bruce Hedden David

John Bryson Nathan

L De Somer Marc

Original Assignee

Sunovion Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-06-12

Filing date

2010-06-11

Publication date

2018-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43309244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2952191(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-06-11 Application filed by Sunovion Pharmaceuticals Inc filed Critical Sunovion Pharmaceuticals Inc

2018-11-30 Publication of PT2952191T publication Critical patent/PT2952191T/pt

Links

VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 title 1
229960004046 apomorphine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Inorganic Chemistry (AREA)
Emergency Medicine (AREA)
Zoology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Psychology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PT15175258T 2009-06-12 2010-06-11 Apomorfina sublingual PT2952191T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US18644509P	2009-06-12	2009-06-12

Publications (1)

Publication Number	Publication Date
PT2952191T true PT2952191T (pt)	2018-11-30

Family

ID=43309244

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT15175258T PT2952191T (pt)	2009-06-12	2010-06-11	Apomorfina sublingual
PT107869158T PT2442650E (pt)	2009-06-12	2010-06-11	Apomorfina sublingual

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PT107869158T PT2442650E (pt)	2009-06-12	2010-06-11	Apomorfina sublingual

Country Status (20)

Country	Link
US (10)	US9044475B2 (pt)
EP (3)	EP2442650B2 (pt)
JP (6)	JP5760295B2 (pt)
KR (5)	KR102086311B1 (pt)
CN (1)	CN102480958B (pt)
AU (4)	AU2010259971C1 (pt)
BR (1)	BR112012000204B8 (pt)
CA (1)	CA2765291C (pt)
DK (2)	DK2952191T3 (pt)
EA (1)	EA025054B1 (pt)
ES (2)	ES2554626T5 (pt)
FI (1)	FI2442650T4 (pt)
HU (1)	HUE028121T2 (pt)
IL (2)	IL216923A (pt)
MX (1)	MX2011013260A (pt)
NZ (1)	NZ597237A (pt)
PL (2)	PL2952191T3 (pt)
PT (2)	PT2952191T (pt)
WO (1)	WO2010144817A1 (pt)
ZA (1)	ZA201109208B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20110033542A1 (en) *	2009-08-07	2011-02-10	Monosol Rx, Llc	Sublingual and buccal film compositions
WO2010086989A1 (ja)	2009-01-29	2010-08-05	日東電工株式会社	口腔内フィルム状基剤及び製剤
PT2952191T (pt) *	2009-06-12	2018-11-30	Sunovion Pharmaceuticals Inc	Apomorfina sublingual
JP5751868B2 (ja) *	2010-03-30	2015-07-22	日東電工株式会社	フィルム状製剤及びその製造方法
EP2651357B1 (en) *	2010-12-16	2020-04-01	Sunovion Pharmaceuticals Inc.	Sublingual films
WO2013026000A1 (en) *	2011-08-17	2013-02-21	Board Of Regents, The University Of Texas System	Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
JP5841433B2 (ja)	2012-01-11	2016-01-13	日東電工株式会社	口腔内フィルム状基剤及び製剤
US20140073678A1 (en) *	2012-09-12	2014-03-13	Monosol Rx, Llc	Anti-pain and anti-nausea and/or vomiting combinatorial compositions
GB201217419D0 (en) *	2012-09-28	2012-11-14	Innotesto Bvba	Improvements in or relating to oromucosal apomorphine compositions
JP2016535794A (ja) *	2013-11-11	2016-11-17	インパックスラボラトリーズ，インコーポレーテッド	急速崩壊性製剤及びその使用法
EP2979688A1 (en)	2014-08-01	2016-02-03	Britannia Pharmaceuticals Limited	Composition containing Apomorphine and a Divalent Metal Cation
EP4578461A3 (en) *	2015-04-21	2025-09-03	Sumitomo Pharma America, Inc.	Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa
CA3015172A1 (en)	2016-02-18	2017-08-24	Privo Technologies, Inc.	Two-stage microparticle-based therapeutic delivery system and method
US11378950B2 (en)	2016-12-22	2022-07-05	Nissan North America, Inc.	Remote system for an autonomous vehicle
WO2018151849A1 (en)	2017-02-17	2018-08-23	Privo Technologies, Inc.	Particle-based multi-layer therapeutic delivery device and method
DE102017108611A1 (de) *	2017-04-21	2018-10-25	Technische Universität Clausthal	Energie-effizientes lösungsmittelfreies Verfahren zur Herstellung von Aminosäure-Metallchelaten
US10478403B1 (en)	2017-05-03	2019-11-19	Privo Technologies, Inc.	Intraoperative topically-applied non-implantable rapid release patch
JP6958860B2 (ja) *	2017-11-07	2021-11-02	学校法人自治医科大学	ミトコンドリアの機能障害の改善剤、及びミトコンドリアの機能障害に起因する疾患又は症状の予防又は治療薬、並びにそれらの用途
WO2019165208A1 (en) *	2018-02-22	2019-08-29	Avior, Inc.	Transmucosal film composition and methods of making and using the same
WO2019175290A1 (en)	2018-03-13	2019-09-19	Beckley Canopy Therapeutics Limited	Cannabis or cannabis derived compositions for promoting cessation of chemical dependence
WO2020006073A1 (en)	2018-06-28	2020-01-02	Arx, Llc	Dispensing method for producing dissolvable unit dose film constructs
US20220241156A1 (en)	2019-06-27	2022-08-04	Sunovion Pharmaceuticals Inc.	Child-resistant dispensers for thin strip medications
US11179331B1 (en)	2020-04-21	2021-11-23	Cure Pharmaceutcai Holding Corp	Oral soluble film containing sildenafil citrate
EP4181875A1 (en) *	2020-07-15	2023-05-24	Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.	Oral cavity polymeric delivery systems
CN117580570A (zh)	2021-06-01	2024-02-20	派沃技术公司	增强的两阶段微粒基局部治疗性递送系统
CN115671106B (zh) *	2021-07-21	2024-03-19	广州新济药业科技有限公司	吗啡的应用
CN121443315A (zh)	2023-07-05	2026-01-30	上海汉都医药科技有限公司	药物组合物、含其的制剂、套装及其制备方法和应用
WO2025259725A1 (en) *	2024-06-11	2025-12-18	Nano Pharmasolutions, Inc.	Apomorphine compositions and therapeutic applications
WO2026092665A1 (en) *	2024-10-31	2026-05-07	Alar Pharmaceuticals Inc.	Apomorphine salts, their formulations and uses thereof

Family Cites Families (111)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1234123A (en) *	1915-08-25	1917-07-24	Charles L Bond	Weighing device.
US3972995A (en)	1975-04-14	1976-08-03	American Home Products Corporation	Dosage form
DE3013839A1 (de)	1979-04-13	1980-10-30	Freunt Ind Co Ltd	Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
US4687773A (en)	1983-03-28	1987-08-18	Mclean Hospital	(+)-N-N-propylnorapomorphine and selective limbic activity
US4746508A (en)	1983-06-06	1988-05-24	Beth Israel Hospital Assn.	Drug administration
US4614545A (en) *	1985-08-15	1986-09-30	The Dow Chemical Company	Hydroxypropyl methyl cellulose thickening agents for organic liquids
US5047244A (en)	1988-06-03	1991-09-10	Watson Laboratories, Inc.	Mucoadhesive carrier for delivery of therapeutical agent
DE4018247A1 (de) *	1990-06-07	1991-12-12	Lohmann Therapie Syst Lts	Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
US5292520A (en)	1990-09-13	1994-03-08	Akzo N.V.	Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
US5145684A (en)	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
AU642066B2 (en)	1991-01-25	1993-10-07	Nanosystems L.L.C.	X-ray contrast compositions useful in medical imaging
JPH08501529A (ja) *	1992-06-11	1996-02-20	セラテック・インコーポレイテッド	皮膚透過薬剤投与緩和のグリセリン使用
NZ248813A (en)	1992-11-25	1995-06-27	Eastman Kodak Co	Polymeric grinding media used in grinding pharmaceutical substances
US5336507A (en)	1992-12-11	1994-08-09	Sterling Winthrop Inc.	Use of charged phospholipids to reduce nanoparticle aggregation
CN1134163A (zh) *	1993-08-19	1996-10-23	辛勒斯治疗系统公司	水溶性压敏粘膜粘合剂和配备该粘合剂用于放置在有粘膜衬里的体腔内的器具
US6395744B1 (en) *	1994-04-22	2002-05-28	Queen's University At Kingston	Method and compositions for the treatment or amelioration of female sexual dysfunction
CA2188385C (en) *	1994-04-22	2000-07-11	Ragab El-Rashidy	Dosage forms and method for ameliorating male erectile dysfunction
US6566368B2 (en) *	1994-04-22	2003-05-20	Pentech Pharmaceuticals, Inc.	Apomorphine-containing dosage form for ameliorating male erectile dysfunction
US6121276A (en) *	1994-04-22	2000-09-19	Pentech Pharmaceuticals, Inc.	Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
US5718388A (en)	1994-05-25	1998-02-17	Eastman Kodak	Continuous method of grinding pharmaceutical substances
TW384224B (en)	1994-05-25	2000-03-11	Nano Sys Llc	Method of preparing submicron particles of a therapeutic or diagnostic agent
JPH0834731A (ja) *	1994-07-26	1996-02-06	T T S Gijutsu Kenkyusho:Kk	グラニセトロン含有経皮吸収型製剤
US5662883A (en)	1995-01-10	1997-09-02	Nanosystems L.L.C.	Microprecipitation of micro-nanoparticulate pharmaceutical agents
US5665331A (en)	1995-01-10	1997-09-09	Nanosystems L.L.C.	Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers
US5560932A (en)	1995-01-10	1996-10-01	Nano Systems L.L.C.	Microprecipitation of nanoparticulate pharmaceutical agents
US5534270A (en)	1995-02-09	1996-07-09	Nanosystems Llc	Method of preparing stable drug nanoparticles
US5543133A (en)	1995-02-14	1996-08-06	Nanosystems L.L.C.	Process of preparing x-ray contrast compositions containing nanoparticles
US5510118A (en)	1995-02-14	1996-04-23	Nanosystems Llc	Process for preparing therapeutic compositions containing nanoparticles
US5523090A (en)	1995-02-24	1996-06-04	Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.	Skin treatment composition
US5624677A (en)	1995-06-13	1997-04-29	Pentech Pharmaceuticals, Inc.	Controlled release of drugs delivered by sublingual or buccal administration
US5888534A (en) *	1995-06-13	1999-03-30	Pentech Pharmaceuticals, Inc.	Controlled release of drugs delivered by sublingual or buccal administration
GB9517062D0 (en) *	1995-08-18	1995-10-25	Scherer Ltd R P	Pharmaceutical compositions
US5800832A (en)	1996-10-18	1998-09-01	Virotex Corporation	Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US20010006677A1 (en) *	1996-10-29	2001-07-05	Mcginity James W.	Effervescence polymeric film drug delivery system
DE19646392A1 (de)	1996-11-11	1998-05-14	Lohmann Therapie Syst Lts	Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE19652268C2 (de) *	1996-12-16	2000-06-29	Lohmann Therapie Syst Lts	Arzneizubereitung für die Freisetzung von Apomorphin in der Mundhöhle
US6667056B2 (en) *	1997-07-23	2003-12-23	Chiesi Farmaceutici S.P.A.	Pharmaceutical compositions containing an effervescent acid-base couple
US5945117A (en) *	1998-01-30	1999-08-31	Pentech Pharmaceuticals, Inc.	Treatment of female sexual dysfunction
US6974590B2 (en) *	1998-03-27	2005-12-13	Cima Labs Inc.	Sublingual buccal effervescent
US7087240B1 (en) *	1998-06-25	2006-08-08	Lavipharm Laboratories Inc.	Device and method for the treatment of erectile dysfunction
US5994363A (en) *	1998-08-24	1999-11-30	Pentech Pharmaceuticals, Inc.	Amelioration of apomorphine adverse effects
GB9826192D0 (en)	1998-12-01	1999-01-20	Controlled Theraputics Scotlan	Oral transmucosal delivery
US6486207B2 (en)	1998-12-10	2002-11-26	Nexmed (Holdings), Inc.	Compositions and methods for amelioration of human female sexual dysfunction
US6552024B1 (en)	1999-01-21	2003-04-22	Lavipharm Laboratories Inc.	Compositions and methods for mucosal delivery
US6087362A (en) *	1999-03-16	2000-07-11	Pentech Pharmaceuticals, Inc.	Apomorphine and sildenafil composition
US6375963B1 (en)	1999-06-16	2002-04-23	Michael A. Repka	Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
WO2001017543A2 (en) *	1999-09-03	2001-03-15	Amgen Inc.	Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
US6264981B1 (en)	1999-10-27	2001-07-24	Anesta Corporation	Oral transmucosal drug dosage using solid solution
DE19954245A1 (de) *	1999-11-11	2001-07-19	Lohmann Therapie Syst Lts	Mehrschichtige filmförmige Zubereitung aus hydrophilen Polymeren zur schnellen Freisetzung von Wirkstoffen
DE19954421A1 (de) *	1999-11-12	2001-05-31	Lohmann Therapie Syst Lts	Filmförmige Zubereitung zur biphasigen Freisetzung pharmakologisch wirksamer oder anderer Substanzen
HUP0400495A3 (en) *	1999-12-30	2007-05-02	Tap Pharmaceutical Prod Inc	Oral mucosal dosage forms of apomorphine, suitable for the administration via oral mucosal tissue
SE0102036D0 (sv)	2001-06-08	2001-06-08	Axon Biochemicals Bv	Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
SE0002934D0 (sv) *	2000-08-17	2000-08-17	Axon Biochemicals Bv	New aporphine esters and in their use in therapy
WO2002043580A2 (en)	2000-10-27	2002-06-06	Epic Therapeutics, Inc.	Production of microspheres
US6756051B1 (en)	2000-11-15	2004-06-29	Li-Lan H. Chen	Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same
EP1365740A1 (en)	2001-02-08	2003-12-03	Pharmacia Corporation	Rapid-onset medicament for the treatment of sexual dysfunction
US6976647B2 (en)	2001-06-05	2005-12-20	Elan Pharma International, Limited	System and method for milling materials
JP2003006170A (ja) *	2001-06-20	2003-01-10	Hitachi Ltd	複数計算機環境でのプログラム実行方法
US20040028613A1 (en)	2001-06-25	2004-02-12	Nastech Pharmaceutical Company Inc	Dopamine agonist formulations for enhanced central nervous system delivery
US20030068356A1 (en)	2001-07-10	2003-04-10	Pather S. Indiran	Sequential drug delivery systems
US7666337B2 (en) *	2002-04-11	2010-02-23	Monosol Rx, Llc	Polyethylene oxide-based films and drug delivery systems made therefrom
US20080050422A1 (en)	2001-10-12	2008-02-28	Monosolrx, Llc.	Method of administering a film product containing a drug
US20110033542A1 (en)	2009-08-07	2011-02-10	Monosol Rx, Llc	Sublingual and buccal film compositions
US8765167B2 (en)	2001-10-12	2014-07-01	Monosol Rx, Llc	Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8663687B2 (en) *	2001-10-12	2014-03-04	Monosol Rx, Llc	Film compositions for delivery of actives
US8603514B2 (en) *	2002-04-11	2013-12-10	Monosol Rx, Llc	Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7357891B2 (en) *	2001-10-12	2008-04-15	Monosol Rx, Llc	Process for making an ingestible film
US7425292B2 (en) *	2001-10-12	2008-09-16	Monosol Rx, Llc	Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US20070281003A1 (en)	2001-10-12	2007-12-06	Fuisz Richard C	Polymer-Based Films and Drug Delivery Systems Made Therefrom
US7910641B2 (en) *	2001-10-12	2011-03-22	Monosol Rx, Llc	PH modulated films for delivery of actives
FR2832311B1 (fr) *	2001-11-21	2004-04-16	Besins Int Belgique	Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
KR20050008658A (ko)	2002-03-19	2005-01-21	마이클 홀릭	아포모르핀의 글리코시드 및 오르토에스테르 글리코시드유도체들, 유사체들 및 그것의 용도
US8017150B2 (en) *	2002-04-11	2011-09-13	Monosol Rx, Llc	Polyethylene oxide-based films and drug delivery systems made therefrom
US6566359B1 (en) *	2002-05-20	2003-05-20	Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College	2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid esters as neuroprotective drugs
DE10224612A1 (de)	2002-06-04	2003-12-24	Lohmann Therapie Syst Lts	Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
GB0221711D0 (en)	2002-09-19	2002-10-30	Ardana Bioscience Ltd	Methods
JP2006508122A (ja) *	2002-11-12	2006-03-09	テバファーマシューティカルインダストリーズリミティド	チザニジンの頬及び舌下デリバリーのための医薬組成物及び投与形態並びにチザニジンを舌下又は頬に投与する方法
US20040136923A1 (en)	2002-11-14	2004-07-15	Davidson R Steven	Edible film for relief of cough or symptoms associated with pharyngitis
US9561182B2 (en)	2003-08-22	2017-02-07	Cure Pharmaceutical Corporation	Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US8999372B2 (en)	2002-11-14	2015-04-07	Cure Pharmaceutical Corporation	Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
WO2004066986A1 (en)	2003-01-30	2004-08-12	Monosolrx Llc	Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US20040202693A1 (en) *	2003-04-14	2004-10-14	Rong-Kun Chang	Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem
US20040204439A1 (en) *	2003-04-14	2004-10-14	Staniforth John Nicholas	Composition, device, and method for treating sexual dysfunction via inhalation
AU2004319243B2 (en)	2003-05-28	2010-06-03	Aquestive Therapeutics, Inc.	Polyethylene oxide-based films and drug delivery systems made therefrom
CN1460476A (zh) *	2003-06-08	2003-12-10	胡秀爱	可调释药速率的阿扑吗啡舌下滴丸制剂
PL2446881T3 (pl)	2003-07-24	2014-08-29	Glaxosmithkline Llc	Folie rozpuszczające się w jamie ustnej
US9248146B2 (en) *	2003-10-24	2016-02-02	Adhesives Research, Inc.	Dissolvable adhesive films for delivery of pharmaceutical or cosmetic agents
DE602004031771D1 (de)	2003-12-31	2011-04-21	Cima Labs Inc	Brauseformen von opiaten zur oralen anwendung und verfahren zur verabreichung von oxycodon
EP1713450B1 (en)	2004-01-30	2021-10-06	Corium, Inc.	Rapidly dissolving film for delivery of an active agent
KR20130116378A (ko) *	2004-02-17	2013-10-23	트랜스셉트 파마슈티칼스, 인코포레이티드	구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
JP4413665B2 (ja) *	2004-03-19	2010-02-10	救急薬品工業株式会社	口腔内粘膜フィルム剤
JP2007532670A (ja)	2004-04-13	2007-11-15	ザマクレーンホスピタルコーポレーション	Ｒ（−）−１１−ヒドロキシアポルフィン誘導体およびその使用方法
CA2581851C (en)	2004-09-30	2016-11-01	Monosolrx Llc	Multi-layer films having uniform content
RU2283650C1 (ru)	2005-02-24	2006-09-20	Закрытое Акционерное Общество "Канонфарма Продакшн"	Твердая лекарственная форма для улучшения мужской эректильной функции
FR2883179B1 (fr) *	2005-03-18	2009-04-17	Ethypharm Sa	Comprime enrobe
GB0509317D0 (en) *	2005-05-06	2005-06-15	Clarke Anthony	Pharmaceutical formulation of apomorphine
DE102005041860A1 (de) *	2005-09-02	2007-03-08	Schering Ag	Nanopartikulärer Einschluss- und Ladungskomplex für pharmazeutische Formulierungen
CA2621263A1 (en)	2005-09-09	2007-03-15	Garry L. Myers	Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
AU2006322050A1 (en)	2005-12-06	2007-06-14	Monosol Rx, Llc	Topical film compositions for delivery of actives
JP2009521532A (ja) *	2005-12-27	2009-06-04	モノソルアールエックスリミテッドライアビリティカンパニー	活性物質を放出するための、ｐＨ調節されたフィルム
US20070286900A1 (en) *	2006-06-09	2007-12-13	Catherine Herry	Low dose tablets of opioid analgesics and preparation process
AU2007275581B2 (en)	2006-07-21	2011-09-08	Biodelivery Sciences International, Inc.	Transmucosal delivery devices with enhanced uptake
AU2007304425B2 (en)	2006-10-02	2013-12-05	Spepharma Ag	Non-mucoadhesive film dosage forms
US20100035886A1 (en) *	2007-06-21	2010-02-11	Veroscience, Llc	Parenteral formulations of dopamine agonists
US7843456B2 (en) *	2007-06-29	2010-11-30	Microsoft Corporation	Gradient domain editing of animated meshes
EP2214478A1 (en) *	2007-10-19	2010-08-11	Innozen, Inc.	Composition for administering an active ingredient and method for making and using the same
EP2210595A1 (en) *	2009-01-14	2010-07-28	LEK Pharmaceuticals d.d.	Active coating of pharmaceutical dosage forms
SG175891A1 (en) *	2009-05-08	2011-12-29	Genentech Inc	Humanized anti-egfl7 antibodies and methods using same
PT2952191T (pt)	2009-06-12	2018-11-30	Sunovion Pharmaceuticals Inc	Apomorfina sublingual
EP2651357B1 (en)	2010-12-16	2020-04-01	Sunovion Pharmaceuticals Inc.	Sublingual films
GB201217419D0 (en)	2012-09-28	2012-11-14	Innotesto Bvba	Improvements in or relating to oromucosal apomorphine compositions

2010
- 2010-06-11 PT PT15175258T patent/PT2952191T/pt unknown
- 2010-06-11 CA CA2765291A patent/CA2765291C/en active Active
- 2010-06-11 CN CN201080035644.4A patent/CN102480958B/zh not_active Expired - Fee Related
- 2010-06-11 JP JP2012515185A patent/JP5760295B2/ja not_active Expired - Fee Related
- 2010-06-11 EA EA201270012A patent/EA025054B1/ru unknown
- 2010-06-11 WO PCT/US2010/038336 patent/WO2010144817A1/en not_active Ceased
- 2010-06-11 EP EP10786915.8A patent/EP2442650B2/en active Active
- 2010-06-11 FI FIEP10786915.8T patent/FI2442650T4/fi active
- 2010-06-11 KR KR1020197025080A patent/KR102086311B1/ko not_active Expired - Fee Related
- 2010-06-11 US US12/813,820 patent/US9044475B2/en active Active
- 2010-06-11 ES ES10786915T patent/ES2554626T5/es active Active
- 2010-06-11 BR BR112012000204A patent/BR112012000204B8/pt not_active IP Right Cessation
- 2010-06-11 PL PL15175258T patent/PL2952191T3/pl unknown
- 2010-06-11 ES ES15175258T patent/ES2699077T3/es active Active
- 2010-06-11 KR KR1020187016580A patent/KR102017009B1/ko not_active Expired - Fee Related
- 2010-06-11 EP EP15175258.1A patent/EP2952191B1/en active Active
- 2010-06-11 KR KR1020167033187A patent/KR20170027711A/ko not_active Ceased
- 2010-06-11 MX MX2011013260A patent/MX2011013260A/es unknown
- 2010-06-11 PL PL10786915.8T patent/PL2442650T5/pl unknown
- 2010-06-11 HU HUE10786915A patent/HUE028121T2/en unknown
- 2010-06-11 KR KR1020157016545A patent/KR20150094648A/ko not_active Ceased
- 2010-06-11 DK DK15175258.1T patent/DK2952191T3/en active
- 2010-06-11 AU AU2010259971A patent/AU2010259971C1/en not_active Ceased
- 2010-06-11 KR KR1020127000835A patent/KR20120042836A/ko not_active Ceased
- 2010-06-11 PT PT107869158T patent/PT2442650E/pt unknown
- 2010-06-11 EP EP18189805.7A patent/EP3434270A1/en not_active Withdrawn
- 2010-06-11 DK DK10786915.8T patent/DK2442650T4/da active
- 2010-06-11 NZ NZ597237A patent/NZ597237A/en not_active IP Right Cessation
2011
- 2011-12-12 IL IL216923A patent/IL216923A/en active IP Right Grant
- 2011-12-14 ZA ZA2011/09208A patent/ZA201109208B/en unknown
2015
- 2015-04-10 US US14/684,146 patent/US9326981B2/en active Active
- 2015-05-22 JP JP2015104145A patent/JP6141354B2/ja not_active Expired - Fee Related
- 2015-12-08 US US14/962,806 patent/US20160095851A1/en not_active Abandoned
- 2015-12-09 US US14/963,971 patent/US9669020B2/en not_active Expired - Fee Related
- 2015-12-09 US US14/963,835 patent/US9669018B2/en not_active Expired - Fee Related
- 2015-12-09 US US14/963,910 patent/US9669019B2/en not_active Expired - Fee Related
- 2015-12-16 US US14/971,532 patent/US9669021B2/en not_active Expired - Fee Related
2016
- 2016-03-11 JP JP2016047759A patent/JP6267254B2/ja not_active Expired - Fee Related
2017
- 2017-01-18 AU AU2017200329A patent/AU2017200329B2/en not_active Ceased
- 2017-08-13 IL IL253965A patent/IL253965B/en unknown
- 2017-12-21 JP JP2017244979A patent/JP6506381B2/ja not_active Expired - Fee Related
2018
- 2018-06-11 US US16/005,105 patent/US10420763B2/en active Active
2019
- 2019-01-17 AU AU2019200308A patent/AU2019200308B2/en not_active Ceased
- 2019-03-28 JP JP2019062669A patent/JP6770126B2/ja not_active Expired - Fee Related
- 2019-08-08 US US16/535,501 patent/US20200030315A1/en not_active Abandoned
2020
- 2020-09-24 JP JP2020159220A patent/JP2021001209A/ja active Pending
2021
- 2021-02-26 AU AU2021201259A patent/AU2021201259A1/en not_active Abandoned
- 2021-02-26 US US17/186,439 patent/US20210322403A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US9326981B2 (en)	2016-05-03
AU2017200329B2 (en)	2018-11-08
AU2010259971B2 (en)	2016-10-27
ZA201109208B (en)	2013-09-25
JP2016147882A (ja)	2016-08-18
DK2952191T3 (en)	2018-12-10
NZ597237A (en)	2014-02-28
EP3434270A1 (en)	2019-01-30
ES2554626T5 (en)	2025-10-06
US20150216859A1 (en)	2015-08-06
US10420763B2 (en)	2019-09-24
EA025054B1 (ru)	2016-11-30
AU2019200308A1 (en)	2019-02-07
KR20150094648A (ko)	2015-08-19
BR112012000204A8 (pt)	2017-09-19
US20160095851A1 (en)	2016-04-07
JP5760295B2 (ja)	2015-08-05
JP6267254B2 (ja)	2018-01-24
PL2442650T5 (pl)	2025-09-08
US9044475B2 (en)	2015-06-02
US20160089328A1 (en)	2016-03-31
AU2017200329A1 (en)	2017-02-23
JP2012530066A (ja)	2012-11-29
JP2021001209A (ja)	2021-01-07
US9669019B2 (en)	2017-06-06
US9669018B2 (en)	2017-06-06
BR112012000204B8 (pt)	2021-05-25
KR20190103472A (ko)	2019-09-04
PL2442650T3 (pl)	2016-01-29
KR20120042836A (ko)	2012-05-03
EP2442650A4 (en)	2012-11-14
US20160089367A1 (en)	2016-03-31
HK1218630A1 (en)	2017-03-03
HK1171340A1 (zh)	2013-03-28
EP2952191B1 (en)	2018-08-22
PT2442650E (pt)	2015-12-18
BR112012000204B1 (pt)	2020-11-24
EP2442650B2 (en)	2025-05-14
DK2442650T3 (en)	2015-12-07
PL2952191T3 (pl)	2019-02-28
CA2765291C (en)	2016-03-08
CA2765291A1 (en)	2010-12-16
US9669021B2 (en)	2017-06-06
KR102086311B1 (ko)	2020-03-06
CN102480958A (zh)	2012-05-30
KR20180069100A (ko)	2018-06-22
ES2699077T3 (es)	2019-02-07
IL253965A0 (en)	2017-10-31
US20160081914A1 (en)	2016-03-24
HUE028121T2 (en)	2016-11-28
EP2442650A1 (en)	2012-04-25
JP2015199743A (ja)	2015-11-12
FI2442650T4 (fi)	2025-08-06
JP2018083820A (ja)	2018-05-31
US9669020B2 (en)	2017-06-06
US20200030315A1 (en)	2020-01-30
JP6506381B2 (ja)	2019-04-24
KR20170027711A (ko)	2017-03-10
JP2019123732A (ja)	2019-07-25
CN102480958B (zh)	2015-08-19
JP6141354B2 (ja)	2017-06-07
AU2010259971A1 (en)	2012-01-19
EP2442650B1 (en)	2015-08-26
MX2011013260A (es)	2012-02-28
DK2442650T4 (en)	2025-08-18
US20210322403A1 (en)	2021-10-21
AU2021201259A1 (en)	2021-03-18
JP6770126B2 (ja)	2020-10-14
ES2554626T3 (es)	2015-12-22
KR102017009B1 (ko)	2019-09-02
AU2019200308B2 (en)	2020-11-26
WO2010144817A1 (en)	2010-12-16
US20110111011A1 (en)	2011-05-12
US20180289699A1 (en)	2018-10-11
BR112012000204A2 (pt)	2016-11-01
AU2010259971C1 (en)	2017-02-16
EP2952191A1 (en)	2015-12-09
IL216923A0 (en)	2012-02-29
IL216923A (en)	2017-08-31
IL253965B (en)	2022-06-01
US20160101101A1 (en)	2016-04-14
EA201270012A1 (ru)	2012-07-30

Publication	Publication Date	Title
IL253965B (en)	2022-06-01	Sublingual apomorphine
IL213794A0 (en)	2011-07-31	Novel uses
EP2483254A4 (en)	2013-02-27	NEW COMPOUNDS
GB0905955D0 (en)	2009-05-20	Novel compounds
ZA201109437B (en)	2013-03-27	Novel azabicyclohexanes
EP2456311A4 (en)	2013-01-23	SUBSTITUTED IMIDASOTRIAZINES
IL214232A0 (en)	2011-09-27	Novel tricyanoborates
ZA201108565B (en)	2013-01-30	Substituted piperidnes
EP2512242A4 (en)	2013-08-28	NEW COMPOUNDS
GB0908435D0 (en)	2009-06-24	Processes
GB2483195B (en)	2015-02-11	Novel uses
GB0904677D0 (en)	2009-04-29	Novel case
GB0916844D0 (en)	2009-11-04	Novel case
GB2483404B (en)	2013-08-07	Hand scabbler
GB0900924D0 (en)	2009-03-04	Instant kofta
GB0909661D0 (en)	2009-07-22	Watercraft
GB0908544D0 (en)	2009-06-24	Downpipe
GB0912940D0 (en)	2009-09-02	Endoperoxides
GB0904353D0 (en)	2009-04-29	Novel thiazolopyrimidines
GB0912995D0 (en)	2009-09-02	Tiles cover
ZA200906707B (en)	2010-06-30	Template-fixed peptidomimetics
GB0907825D0 (en)	2009-06-17	Novel compound
GB0915041D0 (en)	2009-09-30	Hands free travel-ostomy
AU328406S (en)	2009-11-12	Tile
AU325935S (en)	2009-05-11	Tile